Accelerated Pharma (Accelerated Pharma) Median PS Value : $0.00 (As of May. 20, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Accelerated Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2017 was $0. Accelerated Pharma's 10-Year median PS Ratio is . Therefore, the Median PS Value for today is $0.00.

As of today (2024-05-20), Accelerated Pharma's share price is $0.00. Accelerated Pharma's Median PS Value is $0.00. Therefore, Accelerated Pharma's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Accelerated Pharma's Median PS Value or its related term are showing as below:

ACCP's Price-to-Median-PS-Value is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.85
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Accelerated Pharma Median PS Value Historical Data

The historical data trend for Accelerated Pharma's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma Median PS Value Chart

Accelerated Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Median PS Value

Accelerated Pharma Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Median PS Value	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Accelerated Pharma's Median PS Value

For the Drug Manufacturers - Specialty & Generic subindustry, Accelerated Pharma's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Accelerated Pharma's Price-to-Median-PS-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Accelerated Pharma's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Accelerated Pharma's Price-to-Median-PS-Value falls into.

Accelerated Pharma Median PS Value Calculation

Accelerated Pharma's Median PS Value for today is calculated as

Median PS Value	=	Revenue per Share (TTM)	*	10-Year Median PS Ratio
	=	0	*
	=	0.00

10-Year Median PS Ratio is .
Accelerated Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.

Accelerated Pharma (NAS:ACCP) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Accelerated Pharma's Price to Median PS Value for today is calculated as

Price to Median PS Value	=	Share Price	/	Median PS Value
	=	0.00	/	0.00
	=

Accelerated Pharma Median PS Value Related Terms

Thank you for viewing the detailed overview of Accelerated Pharma's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Accelerated Pharma (Accelerated Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » Median PS Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines